Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Notes Payables (2017 - 2021)

Updated

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Notes Payables (2017 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 29,088.00
Jun 30, 2018 234,341.00
Dec 31, 2017 234,313.00
API Access

Azora Therapeutics, Inc. (DE) Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=AZR&period=max&api_key=YOUR_API_KEY